Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867346 · ClinicalTrials.gov registry record

Early Markers of Cognitive Change and Alzheimer s Disease

A clinical trial, sponsored by National Institute on Aging (NIA).

Completed
Registry status
2,850
Enrollment target

NCT01867346 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 2,850 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867346 has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
2,850 participants
Enrollment target

Study Summary

Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a long-term study of human aging. To see how the brain changes with age, researchers will study BLSA participants who are at least 60 years old. In particular, researchers are looking for early markers of possible Alzheimer's disease and other conditions that cause memory loss. To do so, they will give tests of memory and brain function, and stay in close contact with participants. Objectives: \- To study cognitive changes that occur in normal aging and in people who develop memory problems. Eligibility: \- Individuals at least 60 years of age who are participating in the BLSA. Design: * There are three parts to this study. These study procedures will be done under the usual BLSA guidelines. * Participants will take paper and pencil tests. The tests measure skills such as language, attention, memory, and problem solving. They will also ask questions about emotions and feelings. * Participants will give the name and phone number of a person who knows them well and sees them often. Researchers will ask this person to fill out questionnaires on the effects of aging on the participant. These questions will monitor the participant's memory and ability to function independently. * Participants will have regular phone calls between study visits. These calls will help to keep their information up to date. * Participants will continue on this study for as long as they are able to participate.

Trial Details

FieldValue
Enrollment Target 2,850 participants
Start Date 2003-03-19
Est. Completion 2015-01-02

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT01867346

The ClinicalTrials.gov registry entry for NCT01867346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,850 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01867346 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01867346 about?

NCT01867346 is a clinical study titled "Early Markers of Cognitive Change and Alzheimer s Disease". Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a long-term study of human aging. To see how the brain changes with age, researchers will study BLSA participants who are at least 60 years old. In particular, researchers are looking for early markers of possible Alzheimer's diseas...

What is the current status of trial NCT01867346?

This trial is currently completed. The enrollment target is 2,850 participants. The study started on 2003-03-19. Estimated completion is 2015-01-02.

Who is sponsoring clinical trial NCT01867346?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.